Integra LifeSciences Holdings Corporation (IART)
NASDAQ: IART · Real-Time Price · USD
9.89
-0.50 (-4.81%)
At close: Mar 5, 2026, 4:00 PM EST
9.97
+0.08 (0.81%)
After-hours: Mar 5, 2026, 4:36 PM EST
IART Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for IART stock have an average target of 14.83, with a low estimate of 11 and a high estimate of 25. The average target predicts an increase of 49.95% from the current stock price of 9.89.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for IART stock from 7 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 3 | 3 | 3 | 3 | 3 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 6 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Hold Maintains $13 → $12 | Hold | Maintains | $13 → $12 | +21.33% | Feb 27, 2026 |
| Truist Securities | Truist Securities | Hold Reiterates $15 → $13 | Hold | Reiterates | $15 → $13 | +31.45% | Nov 3, 2025 |
| Citigroup | Citigroup | Strong Sell Maintains $12 → $11 | Strong Sell | Maintains | $12 → $11 | +11.22% | Oct 31, 2025 |
| JP Morgan | JP Morgan | Sell Maintains $12 → $13 | Sell | Maintains | $12 → $13 | +31.45% | Oct 31, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $13 → $15 | Hold | Maintains | $13 → $15 | +51.67% | Oct 15, 2025 |
Financial Forecast
Revenue This Year
1.71B
from 1.64B
Increased by 4.45%
Revenue Next Year
1.77B
from 1.71B
Increased by 3.40%
EPS This Year
2.39
from -6.74
EPS Next Year
2.60
from 2.39
Increased by 8.96%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.8B | 1.8B | |
| Avg | 1.7B | 1.8B | |
| Low | 1.6B | 1.7B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 8.1% | 7.4% | |
| Avg | 4.4% | 3.4% | |
| Low | -0.3% | -1.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 2.49 | 2.86 | |
| Avg | 2.39 | 2.60 | |
| Low | 2.22 | 2.37 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | 19.7% | |
| Avg | - | 9.0% | |
| Low | - | -0.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.